US Patent 12110312 Integrated continuous manufacturing of therapeutic protein drug substances
Patent 12110312 was granted and assigned to Genzyme on October, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12110312 Integrated continuous manufacturing of therapeutic protein drug substances
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
